CEO and Co-Founder, Tamr
Partner at New Enterprise Associates
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder, The Haul Company
Recent breakthroughs have enabled E. Edward Baetge’s team at San Diego-based Novocell to develop and patent an innovative stem cell therapy that yields functional pancreatic, insulin-producing cells using human embryonic stem cells. Baetge outlines development of a potential therapy that injects such stem cells into the bodies of diabetics to replace cells that no longer produce insulin. More information and online registration is available here.